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Abstract
Background: While cultivation of pathogens represents a foundational diagnostic approach in the study of
infectious diseases, its value for the confirmation of clinical diagnosis of Buruli ulcer is limited by the fact that
colonies of Mycobacterium ulcerans appear only after about eight weeks of incubation at 30°C. However, for
molecular epidemiological and drug sensitivity studies, primary isolation of M. ulcerans remains an essential tool.
Since for most of the remote Buruli ulcer endemic regions of Africa cultivation laboratories are not easily accessible,
samples from lesions often have to be stored for extended periods of time prior to processing. The objective of the
current study therefore was to determine which transport medium, decontamination method or other factors
decrease the contamination rate and increase the chance of primary isolation of M. ulcerans bacilli after long
turnover time.
Methods: Swab and fine needle aspirate (FNA) samples for the primary cultivation were collected from clinically
confirmed Buruli ulcer patients in the Mapé Basin of Cameroon. The samples were either stored in the semi-solid
transport media 7H9 or Amies or dry for extended period of time prior to processing. In the laboratory, four
decontamination methods and two inoculation media were evaluated and statistical methods applied to identify
factors that decrease culture contamination and factors that increase the probability of M. ulcerans recovery.
Results: The analysis showed: i) that the use of moist transport media significantly increased the recovery rate of
M. ulcerans compared to samples kept dry; ii) that the choice of the decontamination method had no significant
effect on the chance of M. ulcerans isolation; and iii) that Löwenstein-Jensen supplemented with antibiotics as
inoculation medium yielded the best results. We further found that, ten extra days between sampling and
inoculation lead to a relative decrease in the isolation rate of M. ulcerans by nearly 20%. Finally, collection and
processing of multiple samples per patient was found to significantly increase the M. ulcerans isolation rate.
Conclusions: Based on our analysis we suggest a procedure suitable for the primary isolation of M. ulcerans strains
from patients following long delay between sample collection and processing to establish a M. ulcerans strain
collection for research purposes.
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Background
Buruli ulcer (BU), a neglected tropical disease of the skin
caused by Mycobacterium ulcerans, has been reported
from over 30 countries worldwide with most cases oc-
curring in West Africa. Clinically BU presents with both
non-ulcerative lesions, such as nodules, plaques and
edema, as well as ulcers. The major burden of the dis-
ease falls on children between 5 and 15 years of age
[1,2]. Despite intensive research efforts, both the reser-
voir and the mode of transmission of M. ulcerans have
remained unclear [1]. Currently available methods for la-
boratory diagnosis of BU are microscopy, histopathology,
PCR for the M. ulcerans specific insertion sequence
2404 (IS2404) or primary culturing. Based on the high
sensitivity and specificity, the IS2404 PCR test is consid-
ered the gold standard in BU diagnosis [2]. Historically,
BU was treated by wide excision of lesions and tissue
samples could easily be obtained for laboratory diagno-
sis. Since the introduction of rifampicin and strepto-
mycin combination therapy in 2004 [3], samples for
laboratory testing are fine needle aspirates (FNA) taken
from closed lesions and swab specimens taken from the
undermined edges of ulcers [4].
Although primary culturing of M. ulcerans can provide
a definitive BU diagnosis, the value of this method for
primary diagnosis is strongly hampered by the fact that
colonies take two to three months to appear and even
under optimal conditions the sensitivity of the method is
limited [5,6]. For clinical diagnosis, culturing therefore
only represents an auxiliary to other methods for the la-
boratory confirmation of BU. However, for studies on
treatment efficacy, molecular epidemiology, and drug
sensitivity, primary isolation of M. ulcerans remains
crucial [7,8].
To prevent overgrowth with other faster growing mi-
croorganisms, primary culturing of M. ulcerans requires
decontamination of clinical samples prior to culture in-
oculation [6]. The commonly used decontamination
methods use NaOH and HCl (Petroff and reverse Petroff
method) or oxalic acid (OA). Although necessary to pre-
vent overgrowth, all of these methods have been shown
to have a detrimental effect on the viability of M. ulcerans
[6,9,10]. As for the culturing media on which M. ulcerans
is isolated, PANTA, a mixture of the antibiotics polymyxin
B, amphotericin B, nalidixic acid, trimethoprim and azlo-
cillin, as an additive to Löwenstein–Jensen media can be
used to prevent the growth of a range of microorganisms
but does not have an inhibitory effect on the growth
of M. ulcerans [10].
Since for cultivation of M. ulcerans a sophisticated la-
boratory infrastructure is required, clinical specimens
from BU patients often cannot be processed in a timely
manner. It has been shown that from tissue specimens
transported in semisolid transport medium, positive
cultures can be obtained even if samples were kept at
ambient temperature for more than two months [11].
For FNA samples transported in liquid transport medium
containing PANTA and processed within 2 weeks,
Eddyani et al. further found a sensitivity of in vitro culture
of 17.6%, which was not significantly lower than the cul-
ture positivity rate of 25.0% obtained by culturing tissue
specimens from the same patients [12]. Yeboah-Manu
et al. observed culture sensitivities of 41.7% for FNA sam-
ples from non-ulcerative lesions and of 43.8% for swab
samples if they were transported on ice in transport media
containing PANTA and processed within 24 hours [13].
The same study also yielded similar results when compar-
ing the Petroff and the OA decontamination methods
[13]. Further in a subset of samples in the same study,
33.3% of swabs transported dry and processed between
seven days and one month after collection were culture
positive [13].
For the current study we set out to determine the best
procedure for the cultivation of M. ulcerans from swab
and FNA samples stored over extended periods of time
prior to processing. Specifically, the objectives of the
current study were to determine how transport medium,
decontamination method, inoculated media, transport
time or other factors decrease the contamination rate
and increase the chance of primary isolation of M. ulcerans.
The procedure devised here is suitable for the primary
isolation of M. ulcerans strains from patients following
long delay between sample collection and processing to
establish a strain collection for research purposes.
Methods
Patient recruitment and ethical statement
For the current study samples were collected from BU
patients attending health facilities in the Mapé Basin of
Cameroon [14] between August 2010 and July 2012. Lo-
cally patients were diagnosed and treatment initiated
based on clinical symptoms and if available Ziehl-Neelsen
staining. Samples for laboratory confirmation were col-
lected and processed as described below. Ethical clearance
for the study was obtained from the Cameroon National
Ethics Committee (N°041/CNE/DNM/09 and N°172/
CNE/SE/2011) and the Ethics Committee of Basel (EKBB,
reference no. 53/11). Participation was voluntary and all
patients who participated in the study or their legal guard-
ian provided written informed consent.
Sample collection, storage and transport
Prior to the start of medical treatment FNA were col-
lected from patients with non-ulcerative lesions and
swabs from patients with ulcers. The number of swabs
depended on the number of lesions, lesion size and clin-
ical judgment. FNA were collected with sterile needles
and swabs using individually packed sterile cotton swabs.
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To minimize the handling of needles and avoid any dilu-
tion of the samples in transport medium, FNA were
transferred onto a cotton swab immediately after collec-
tion. These swabs were then processed the same as the
swabs collected from ulcers and in the remainder of the
manuscript we refer to all samples as swabs. Swabs were
stored dry, in 7H9 medium containing PANTA (7H9) or
in the antibiotics free Amies medium (VWR Inter-
national); the latter two being semi-solid transport media.
Sterile 7H9 (Difco Middlebrook, Becton Dickinson and
Company) transport medium was prepared to contain
0.5% Agar-Agar (Merck), 0.2% glycerol (Sigma), 2%
PANTA (Becton Dickinson and Company) and 10%
OADC enrichment (Becton Dickinson and Company)
[11]. Briefly after autoclaving the dissolved 7H9 powder
and the agar, the glycerol, PANTA and OADC were added
and 5 ml portions of the still warm medium was filled into
empty cotton swab tubes (Copan). The transport medium
was stored at 4°C until use. Following sample collection,
swabs were inserted into the tube containing the transport
medium and locally stored at 4°C whenever possible. Due
to the remoteness of the BU endemic areas in which clin-
ical samples for this study were collected, timely transport
to adequately equipped laboratories with sufficient cap-
acity was difficult. Therefore at 4–6 month intervals, sam-
ples were transported to the laboratory at the Swiss
Tropical and Public Health Institute at ambient tempera-
ture. Once in the laboratory, swabs were stored at 4°C
until processing.
PCR, decontamination and primary inoculation
For DNA extraction and culturing, swabs were trans-
ferred to 14 mL McCartney glass bottles (Marienfeld,
Germany) that were filled approximately to one third
with 3 mm diameter glass beads (Marienfeld, Germany)
and 2–5 mL of sterile phosphate buffered saline (PBS).
The bottles were vortexed for 1.5 minutes and DNA was
extracted from 1 mL of the solution as described by
Lavender and Fyfe [15]. Extracts were analyzed in dupli-
cate by IS2404 real-time PCR (qPCR) as previously de-
scribed [15].
Decontamination of 1 mL of the remaining extract in
PBS was performed with 1 mL of 1 M NaOH for 10 mi-
nutes (NaOH_10min), 1 mL of 1 M NaOH for 20 mi-
nutes (NaOH_20min), 1 mL of 5% OA for 30 minutes
(OA_30min) or 1 mL of 5% OA for 1 hour (OA_1h) at
room temperature with occasional vortexing. Some but
not all extracts were decontaminated with multiple de-
contamination methods in parallel (Additional file 1:
Table S1). Decontaminated extracts were diluted with
20 mL of sterile PBS. The decontaminated samples were
then centrifuged for 30 minutes at 3000 g, the super-
natant decanted and the pellet re-suspended in 0.15 to
0.25 mL of sterile PBS. Of the re-suspended pellet,
0.1 mL was transferred to Löwenstein-Jensen (LJ) medium
slants with glycerol (Becton Dickinson and Company) or
the same LJ medium slants supplemented with 2% PANTA
(LJ_PANTA). As with the decontamination methods
above, some but not all re-suspended pellets were inocu-
lated on both media in parallel.
Culture processing and M. ulcerans identification
All inoculated cultures were incubated at 30°C until
M. ulcerans growth could be observed. Slants were regu-
larly examined and discarded if contamination, i.e. over-
growth with other faster growing microorganisms, was
detected. All inoculations with no growth were kept for a
minimum of 25 weeks before discarding. Suspected
M. ulcerans growth was confirmed by colony PCR using
primers MU154 (5’-ggcagttacttcactgcaca-3’) and MU155
(5’-cggtgatcaagcgttcacga-3’) and amplification for 32 cycles
of 30 seconds at 94°C, 30 seconds at 60°C and 1 minute at
72°C. PCR products were resolved in a 1.5% agarose gel.
Statistical analysis
To identify factors that affect the rate of contamination
and recovery of M. ulcerans primary cultures, three sets
of univariate and multivariate statistical analyses, one
with all inoculations and two with subsets, were per-
formed. The factors investigated included: transport
medium, decontamination method, inoculation media,
swab qPCR Ct value, patient qPCR result, the time from
sampling to inoculation and the number of weeks before
diagnosis as reported by the patient.
The first analysis identified differences between inocula-
tions that did not contaminate versus those that did result
in contamination (non-contamination vs. contamination).
This analysis aimed at identifying factors that affect con-
tamination of cultures of samples taken from lesions
clinically suspected of BU, independent of the presence of
M. ulcerans on the swab. Specifically, the data set used for
this analysis included both qPCR positive and negative
swabs and inoculations with any of the three possible out-
comes: M. ulcerans growth, contamination with another
microorganisms or no growth. Swabs with a negative
qPCR result in this data set were assigned a Ct value of
76.80 (reciprocal of the midpoint between zero and the
minimum of 1/Ct). These qPCR negative swabs were in-
cluded in the analysis to investigate general factors that
affect contamination of wound exudates and if the pres-
ence of M. ulcerans affects the rate of contamination.
In the second analysis, a subset of inoculations was an-
alyzed to identify factors that affect M. ulcerans growth
(M. ulcerans growth vs. no growth). All inoculations
with no realistic probability of resulting in M. ulcerans
growth, i.e. contaminated inoculations and inoculations
from swabs that were qPCR negative were excluded
from this analysis.
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Finally in the third analysis, we studied factors that af-
fected the recovery of M. ulcerans if some inoculations
resulted in contamination (M. ulcerans growth vs. con-
tamination or no growth). This subset included all inocu-
lations originating from qPCR positive swabs independent
of their outcome, i.e. also including swabs for which
growth may have been undetectable because of over-
growth by other microorganisms. In this third analysis,
the outcomes “no growth” and “contamination” were
grouped together as the undesired outcome.
Workflows of the swabs included in the three data sets
are shown in Figure 1 and the numbers of samples
decontaminated with two decontamination methods in
parallel are listed in Additional file 1: Table S1.
For the identification of factors that contribute to the
outcomes studied, generalized linear mixed models with
patient identification and identification of each individ-
ual swab as random effects were used. Factors that indi-
vidually had a p-value of the association of less than 0.2
were included in the multivariate analyses. The software
SAS (SAS Institute, Cary, USA; release 9.3), RStudio
(RStudio, Boston, USA, version 0.95.262) and R (The R
Foundation for Statistical Computing; version 2.15.1)
were used to perform the analyses.
Results
Factors affecting the rate of contamination
In total 443 swabs, collected from 73 qPCR confirmed
and 22 non-confirmed patients were included in the
analysis for factors affecting the rate of contamination.
Of all these swabs, 302 were qPCR positive with an aver-
age Ct value of 28.09 (Figure 1A). Of the 1125 culture
inoculations from these swabs, 7.8% (88/1125) resulted
in M. ulcerans growth. The 88M. ulcerans culture posi-
tive inoculations originated from samples collected from
31 patients, which corresponds to a per patient positivity
of 32.6% (31/95; Table 1). Further 52.5% (591/1125) of
the inoculations yielded no growth and 39.6% (446/
1125) resulted in contamination. The median time to de-
tection of contamination was 5.0 (interquartile range
(IQR) = 4.0 to 11.0) days (Table 1). One-to-one analysis
was used to identify factors that should be included in
the multivariate analysis (Additional file 1: Table S2).
When studying the combined effect of factors on the
rate of contamination, we found that the transport
medium had an overall significant (p-value: 0.008) effect
on the probability of contamination. Specifically, swabs
transported dry had a 57.7 times lower probability of
contamination compared to swabs transported in Amies
Figure 1 Workflow for swabs included in the statistical analysis. The complete set of M. ulcerans primary culturing inoculations was used to
identify factors that affect the rate of contamination (non-contamination vs. contamination; A). A subset of the inoculations was used to identify
factors that influence the growth of M. ulcerans in the absence of any contamination (M. ulcerans growth vs. no growth; B) and a second subset
was used to identify factors that affect M. ulcerans growth if some of the inoculations resulted in contamination (M. ulcerans growth vs. contamination
or no growth; C). The number of swabs collected as well as the transport media used and the storage time are shown. Further, the number of qPCR
positive swabs with their average Ct value are given and the numbers of decontaminations as well as inoculations performed are shown. Finally the
number of total inoculations in each of the data sets is indicated.
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medium (Table 2). We found no significant difference in
terms of the rate of contamination between swabs trans-
ported in 7H9 or Amies medium. As also shown in Table 2,
there was no overall significant difference (p-value: 0.266)
in the rate of contamination between the four decontam-
ination methods evaluated here. The inoculated culture
medium on the other hand significantly (p-value: <0.001)
influenced the rate of contamination, with cultures on LJ
having a 3.8 (1/0.264) times higher probability of contam-
ination than cultures inoculated onto LJ_PANTA. The
multivariate analysis further showed that there was a sig-
nificant (p-value: 0.007) interaction between transport
medium and the number of days from sampling to inocu-
lation (Table 2). Finally, both an increase in the Ct value of
the swab (p-value: 0.236) and the storage time from sam-
pling to inoculation (p-value: 0.606) did not have a signifi-
cant effect on the rate of contamination of the cultures
(Table 2). Overall, this analysis to identify conditions that
were best suited to prevent contamination of M. ulcerans
primary cultures suggested that swabs should be stored
dry, any of the evaluated decontamination methods can be
used, cultures should be inoculated onto LJ supplemented
with PANTA and neither the Ct value of the IS2404 qPCR
nor the time from sampling to inoculation had a signifi-
cant effect on the rate of contamination.
Factors affecting the rate of M. ulcerans recovery in
primary culturing
To identify factors that affect the recovery of M. ulcerans,
440 inoculations from 220 qPCR positive swabs ori-
ginating from 66 qPCR positive patients were analyzed.
Only the subset of swabs with a realistic probability of
resulting in M. ulcerans growth, as defined in Mater-
ial and Methods above, were used for this analysis.
The average qPCR Ct value of the swabs was 27.9. Of
all the inoculations included in the analysis, 88 inocu-
lations of exudates collected from 31 patients resulted
in M. ulcerans growth and the rest yielded no growth.
This corresponds to a per inoculation positivity rate of
20.0% (88/440) and a per patient positivity rate of 47.0%
(31/66). Because it was not possible to determine if
the contaminated inoculations could have resulted in
M. ulcerans growth, they were not included in this
analysis (Materials and Methods; Table 1). The median
time to detectable M. ulcerans growth was 67.0 (IQR =
55.0 to 105.2) days (Table 1). One-to-one analyses were
again used to identify factors to be included in the multi-
variate analysis (Additional file 1: Table S3). In the
multivariate analysis, we found that the transport medium
had an overall significant effect (p-value: <0.001) on the
probability of M. ulcerans growth (Table 3). Specifically,
Table 1 Outcomes of M. ulcerans primary culturing
Attribute Non-contamination vs.
contamination#
M. ulcerans growth vs.
no growth##
M. ulcerans growth vs.
contamination or
no growth###
M. ulcerans growth per swab (%) 71/443 (16.03) 71/220 (32.27) 71/302 (23.50)
M. ulcerans growth per decontamination procedure (%) Total 80/680 (11.76) 80/315 (25.40) 80/466 (17.17)
NaOH_10min 21/106 (19.81) 21/59 (35.59) 21/99 (21.21)
NaOH_20min 19/214 (8.88) 19/113 (16.81) 19/139 (13.67)
OA_1h 17/157 (10.83) 17/73 (23.29) 17/118 (14.41)
OA_30min 23/203 (11.33) 23/70 (32.86) 23/110 (20.91)
M. ulcerans growth per inoculation (%) 88/1125 (7.82) 88/440 (20.00) 88/700 (12.57)
M. ulcerans growth per patient (%) 31/95 (32.63) 31/66 (46.97) 31/72 (43.06)
Contamination per swab (%) 284/443 (64.11) - 188/302 (62.25)
Contamination per decontamination procedure (%) Total 346/680 (50.88) - 223/466 (47.85)
NaOH_10min 54/106 (50.94) - 48/99 (48.48)
NaOH_20min 97/214 (45.33) - 58/139 (41.73)
OA_1h 74/157 (47.13) - 54/118 (45.76)
OA_30min 121/203 (59.61) - 63/110 (57.27)
Contamination per inoculation (%) 446/1125 (39.64) - 260/700 (37.14)
No growth (%) 591/1125 (52.53) 352/440 (80.00) 352/700 (50.29)
Days to primary outcome* 5.0 (4.0; 11.0) 67.0 (55.0; 105.2) 67.0 (55.0; 105.2)
#Analysis of 1125 inoculations from 95 patients with contamination as the primary outcome.
##Analysis of 440 inoculations from 66 patients with M. ulcerans growth as the primary outcome.
###Analysis of 700 inoculations from 72 patients with M. ulcerans growth as the primary outcome.
*Median with IQR in parentheses.
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swabs transported dry had a 97.7% reduced chance (p-value
<0.001) of M. ulcerans growth compared to samples trans-
ported in Amies medium (Table 3). Between swabs
transported in Amies or 7H9 medium no significant dif-
ference was found, although transport in Amies medium
had a tendency to increase the chance of M. ulcerans re-
covery (odds ratio for transport in 7H9: 0.304; Table 3).
Further in the multivariate analysis there was no signifi-
cant difference in the chance of M. ulcerans recovery
between the decontamination methods evaluated (p-
value: 0.519) and inoculation on either LJ or
LJ_PANTA (p-value: 0.216). However, with an increase
of the qPCR Ct value by one unit, the probability of
M. ulcerans growth was reduced by 12.1% (p-value: 0.044;
Table 3, 1 - OR) and with every 10 extra days of storage
between sampling and inoculation, the probability of
M. ulcerans growth decreased significantly (p-value:
0.001) by 45.9%. Our analysis further detected a
Table 3 Association§ between M. ulcerans growth and all factors of interest with a relevant effect
Factor Value of factor Odds ratio§ 95% CI odds ratio Overall effect
p-value
Transport medium 7H9 0.304 0.046 - 2.026 <0.001
dry 0.023 0.004 - 0.143
Amies (ref. level) 1.000
Decontamination medium OA_1h 0.414 0.102 - 1.683 0.519
OA_30min 0.697 0.127 - 3.837
NaOH_20min 1.242 0.204 - 7.546
NaOH_10min (ref. level) 1.000
Inoculation media LJ 0.478 0.148 - 1.545 0.216
LJ_PANTA (ref. level) 1.000
Swab qPCR Ct value for an increase in 1 unit Ct 0.879 0.775 - 0.996 0.044
Time from sampling to inoculation for an increase in 10 days 0.001
Interaction of transport medium and days from sampling
to inoculation
when 7H9§§ 0.531 0.320 - 0.881 0.074
when dry§§ 0.880 0.704 - 1.099
when Amies§§ (ref. level) 0.541 0.347 - 0.844
§Adjusted for random effects of the patient and swab.
§§For an increase in 10 days from mean number of days from sampling to inoculation.
Table 2 Association§ between non-contamination and all factors of interest
Factor Value of factor Odds ratio§ 95% CI odds ratio Overall effect
p-value
Transport medium§§ 7H9 1.579 0.632 - 3.944 0.008
dry 57.675 23.704 - 140.334
Amies (ref. level) 1.000
Decontamination medium OA_1h 0.715 0.362 - 1.412 0.266
OA_30min 0.540 0.260 - 1.122
NaOH_20min 0.879 0.383 - 2.016
NaOH_10min (ref. level) 1.000
Inoculation media§§ LJ 0.264 0.162 - 0.429 <0.001
LJ_PANTA (ref. level) 1.000
Swab qPCR Ct value for an increase in 1 unit Ct 0.992 0.978 - 1.006 0.236
Time from sampling to inoculation for an increase in 10 days 0.606
Interaction of transport medium and days
from sampling to inoculation
when 7H9§§§ 0.982 0.824 - 1.171 0.007
when dry§§§ 1.167 1.032 - 1.321
when Amies§§§ (ref. level) 0.799 0.643 - 0.993
§Adjusted for random effects of the patient and swab.
§§An interaction (p-value: <0.001) between transport medium and inoculation media was observed.
§§§For an increase in 10 days from the mean number of days from sampling to inoculation.
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moderately significant (p-value: 0.074) interaction be-
tween the transport time and the transport medium, with
Amies medium having the best chance of M. ulcerans
growth for an increase in transport time by 10 days.
Overall, the analysis to evaluate factors that affect the
recovery of M. ulcerans revealed that: i) storage in either
Amies or 7H9 medium was significantly better than keep-
ing swabs dry; ii) none of the decontamination methods
tested had a significantly better effect on the growth
of M. ulcerans and iii) the M. ulcerans recovery was not
affected by inoculation of samples onto media containing
PANTA. On the other hand, the analysis showed that both
a one unit increase in the Ct value of the IS2404 qPCR
and a 10 day increase in the turnover time of the
samples had a significantly negative effect on the rate of
M. ulcerans recovery.
M. ulcerans recovery versus no growth or contamination
For the identification of factors that affect M. ulcerans
recovery in a scenario where some cultures are contami-
nated, 700 inoculated cultures from 302 qPCR positive
swabs (average qPCR Ct value of 28.09) taken from 72
qPCR positive patients were analyzed. As shown in
Table 1, 88 inoculations collected from 31 patients of
the total 700 inoculations resulted in M. ulcerans
growth. This corresponded to a per patient positivity
rate of 43.1%. Further, 37.1% (260/700) of the inocula-
tions were contaminated and 50.3% (352/700) did not
result in any growth. Analysis of these inoculations in a
multivariate analysis showed, that transport medium had
a significant effect (p-value: 0.019) on the recovery of
M. ulcerans (Table 4). Specifically, swabs transported
in Amies medium showed the best recovery rate of
M. ulcerans, although not significantly better than
7H9 medium (95% CI of OR: 0.269 - 1.415). As also seen
in the analysis for non-contamination (Table 2) and
M. ulcerans growth (Table 3), the decontamination
methods evaluated here did not significantly differ in their
effect on the chance of M. ulcerans recovery (p-value:
0.295; Table 4). On the other hand the use of the inocu-
lated media had a significant (p-value: 0.003) impact on
the chance of M. ulcerans recovery, with the use of LJ as
compared to LJ_PANTA reducing the probability of
M. ulcerans recovery by 65.5%. As further shown in
Table 4, a one unit increase in the qPCR Ct value away
from the mean qPCR Ct value of the inoculated swabs
decreased the chance of M. ulcerans recovery by
10.8% (p-value: 0.011). Furthermore, consistent with the
analysis of factors affecting M. ulcerans growth (Table 3),
the time span from sampling to inoculation significantly
(p-value: 0.006) reduced the chance of M. ulcerans isola-
tion, with a decrease of 19.1% for every 10 extra days of
storage compared to the mean storage time of 80.2 days
(Table 4, Figure 2). As shown in Figure 2, the predicted
probability of M. ulcerans recovery decreased from 61.2%
at zero days of storage to 26.8% within 70 days of storage.
Specifically for swabs with a qPCR Ct value of 27.8, that
were transported in Amies medium, decontaminated
using NaOH for 10 minutes and inoculated onto LJ with
PANTA, a probability of M. ulcerans growth of 61.2% can
be expected if samples were stored for zero days. If the
samples are stored for 50 or 100 days, the predicted prob-
ability decreases to 35.3% and 15.9% respectively.
Overall our analysis of the sample set consisting of only
qPCR positive swabs but including all possible outcomes
of the inoculations, showed that either of the moist trans-
port media increased the chance of M. ulcerans recovery
compared to samples kept dry, none of the decontamin-
ation methods yielded superior results and M. ulcerans
culturing was favored on PANTA supplemented LJ
medium. Further the analysis showed that both a one unit
increase in the Ct value of the IS2404 qPCR and a 10 day
Table 4 Model describing the association§ between M. ulcerans growth versus no growth or contamination and all
factors of interest with a relevant effect
Factor Value of factor Odds ratio§ 95% CI odds ratio Overall effect p-value
Transport medium 7H9 0.617 0.269 - 1.415 0.019
dry 0.248 0.094 - 0.655
Amies (ref. level) 1.000
Decontamination medium OA_1h 0.440 0.182 - 1.062 0.295
OA_30min 0.529 0.203 - 1.375
NaOH_20min 0.739 0.236 - 2.313
NaOH_10min (ref. level) 1.000
Inoculation media LJ 0.345 0.169 - 0.703 0.003
LJ_PANTA (ref. level) 1.000
Swab qPCR Ct value for an increase in 1 unit Ct 0.892 0.818 - 0.974 0.011
Time from sampling to inoculation for an increase in 10 days 0.809 0.695 - 0.941 0.006
§Adjusted for random effects of the patient and swab.
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increase in the turnover time of the samples negatively
impacted the chance of M. ulcerans isolation.
Discussion
In the present study we evaluated the effect of various
factors on the rate of M. ulcerans primary isolation from
clinical specimens to develop a method for M. ulcerans
recovery from samples collected from very remote BU
endemic areas. For this, we examined three sets of inoc-
ulations, i) to identify factors that reduce the rate of con-
tamination of the primary cultures, ii) to determine
which factors increase the rate of M. ulcerans recovery
in a scenario where none of the cultures are contami-
nated and iii) to evaluate the effect of factors in the real-
istic setting where some M. ulcerans growth will be
missed due to the contamination of cultures.
In a study on IS2404 PCR positive tissue biopsies
which were stored for up to 26 weeks in semi-solid
transport medium, Eddyani et al. were able to achieve a
culture positivity rate of 45.2%. This showed that the es-
tablishment of an M. ulcerans strain collection from re-
mote BU endemic areas from tissue samples is possible
[11]. Other studies using either tissue biopsies or swab
and FNA samples and shorter transport times have also
reported culture positivity rates of about 50% with the
rest of the cases, although clinically diagnosed and PCR
confirmed, remaining culture negative [6,13,16,17]. In a
study comparable to the present analysis, Eddyani et al.
cultured M. ulcerans from FNA that were stored for two
weeks before processing and achieved a per sample posi-
tivity rate of 17.6% [12]. In spite of long storage intervals
prior to processing, we have achieved here a per PCR–
reconfirmed-sample positivity rate of 23.5%, correspond-
ing to a PCR-reconfirmed-patient M. ulcerans culture
positivity rate from swab and FNA samples of 43.1%.
Given the similarity in these M. ulcerans recovery rates
in several studies employing different clinical specimens
and approaches, the reason for lack of growth of
M. ulcerans from certain patients should be further in-
vestigated [18].
To increase M. ulcerans recovery rates, Yeboah-Manu
et al. have suggested collecting and processing multiple
swab or FNA samples per patient. To increase the
chance of culture positivity, we have ensured that lesion
exudates were collected from all around ulcers. Further,
we collected and processed several (median = 4; IQR = 2
to 6) swabs from most patients and this repeated sampling
did indeed affect the rate of recovery of M. ulcerans per
patient. Only considering qPCR positive swabs, we ob-
served a significant difference (p-value 0.003) in the num-
ber of swabs collected from culture positive patients
(median: 5; IQR: 3 to 6 swabs) versus the number of swabs
collected from culture negative patients (median: 2; IQR:
1 to 5 swabs). Based on these results, we recommend the
collection of up to five swab samples per patient prior to
treatment start to increase the probability of recovering
the infecting M. ulcerans strain.
In both our analyses for M. ulcerans growth and for
contamination of cultures, there was no significant dif-
ference between swabs transported in 7H9 or Amies
medium. However, based on the lower costs of Amies
transport medium compared to the 7H9 medium (ap-
proximately 0.7 USD per Amies swab and 2.8 USD per
7H9 swab with PANTA and OADC), we recommend
the use of Amies medium for the transport of swabs col-
lected from BU patients.
In our analysis, the number of days for which samples
were stored did not significantly affect the rate of con-
tamination of the inoculated cultures but longer storage
did significantly reduce the rate of M. ulcerans recovery
(Tables 3 and 4, Figure 2). This is contrary to a previous
report of culturing from tissue biopsies which found that
that storage time did not affect the rate of M. ulcerans
recovery [11]. M. ulcerans may thus survive better if
Figure 2 Predicted probabilities for M. ulcerans growth. Based on the M. ulcerans growth vs. no growth or contamination model the
probability of M. ulcerans growth was predicted as a function of transport time for samples transported in Amies medium, decontaminated with
NaOH for 10 minutes, inoculated onto LJ medium supplemented with PANTA and if the Ct value of the qPCR was 27.8. Mean predicted
probability of the M. ulcerans growth rate and 95% confidence intervals are shown.
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transported in the context of a tissue biopsy than as
swab sample. As can be expected, the Ct value of the
IS2404 qPCR had a significant effect on the rate of
M. ulcerans recovery (Tables 3 and 4). On the other hand,
neither the qualitative nor the quantitative qPCR result of
a swab nor the BU status, i.e. the overall patient qPCR re-
sult , had a significant effect on the rate of contamination
of the primary cultures in the one-by-one or the multivari-
ate analysis (Table 2 and Additional file 1: Table S2). In
line with a recent report on secondary infections of BU le-
sions [19], this finding does not support the assumption
that BU lesions are less prone to contamination with sec-
ondary microorganisms than other wounds [20].
In our analysis there was no significant difference be-
tween the four decontamination methods evaluated, al-
though in the univariate analysis for M. ulcerans growth,
NaOH for 10 minutes appeared to outperform the other
decontamination options with borderline significance
(p-value: 0.076, Additional file 1: Table S3). Since 10 min
NaOH is also the quickest decontamination method, we
therefore suggest this one to be used.
Our analysis of M. ulcerans growth vs. contamination or
no growth (Figure 1C), showed that the use of LJ_PANTA
compared to LJ had a significant positive effect (p-value:
0.003) on the rate of recovery of M. ulcerans. This is simi-
lar to what has been found by Yeboah-Manu et al. where
M. ulcerans recovery was also significantly improved
(p-value <0.001) on LJ_PANTA compared to LJ alone [13].
By evaluating a small set of swabs, Yeboah-Manu
et al. have previously been able to show that culturing
from dry cotton swabs is feasible [13]. In our study
we have confirmed this finding. However the chance of
M. ulcerans recovery from swabs stored dry is reduced by
75.2% compared to swabs transported in Amies (Table 4)
and in our analysis dry swabs only achieved a per patient
culture positivity rate of 13.1%.
Conclusions
In conclusion, our results show that primary culturing of
M. ulcerans from cotton swabs after long turnover time
is possible. Based on our findings we suggest that this type
of samples should be transported in Amies medium, that
they should be decontaminated in 0.5 M NaOH for 10 mi-
nutes and that cultures should be inoculated onto LJ
medium supplemented with 2% PANTA. Furthermore,
multiple samples (approximately 5) should be collected
from each patient and only the PCR positive swabs should
be inoculated for culturing.
Overall, the here identified method can help to estab-
lish M. ulcerans strain collections from very remote
BU endemic areas. An increased number of available
M. ulcerans strains from all endemic areas will be a valu-
able resource for studies to increase our understanding of
pathology, transmission and many other aspects of BU.
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